Numerous studies have recently established that the particle number of atherogenic lipoproteins (apoB-containing lipoproteins), and not their cholesterol content nor their type, is the most important attribute for determining ASCVD risk [6,7,8,9,10]. The gene discussed is APOB; the disease is atherosclerosis.